Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Tendons, ligaments, muscles, and gut lining all respond to targeted peptide signaling
Use bacteriostatic water rather than sterile water to enable multi-dose use from single vials
DEXA scans were performed and assessed by blinded personnel, and statistical analyses were planned prior to unblinding at the end of the treatment period
Wegovy pen (semaglutide) is an FDA-approved once-weekly subcutaneous injection for chronic weight management in patients with obesity (body mass index of 30 or more) and overweight (body mass index of 27 or more) with a weight-related condition such as cardiovascular disease, high blood pressure, or type 2 diabetes
US$ 27.20
US$ 26.75
US$ 20.65
